Literature DB >> 18842723

Macrophages in hepatitis B and hepatitis C virus infections.

Mathis Heydtmann1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18842723      PMCID： PMC2655563          DOI： 10.1128/JVI.00996-08

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  99 in total

1.  Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.

Authors:  S J Polyak; K S Khabar; M Rezeiq; D R Gretch
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro.

Authors:  C Caussin-Schwemling; C Schmitt; F Stoll-Keller
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

3.  Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.

Authors:  Jun Wu; Mengji Lu; Zhongji Meng; Martin Trippler; Ruth Broering; Agnes Szczeponek; Frank Krux; Ulf Dittmer; Michael Roggendorf; Guido Gerken; Joerg F Schlaak
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

Review 4.  Immunobiology and pathogenesis of viral hepatitis.

Authors:  Luca G Guidotti; Francis V Chisari
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

5.  Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.

Authors:  Angela Dolganiuc; Oxana Norkina; Karen Kodys; Donna Catalano; Gennadiy Bakis; Christopher Marshall; Pranoti Mandrekar; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

Review 6.  Innate immune response and hepatic inflammation.

Authors:  Gyongyi Szabo; Pranoti Mandrekar; Angela Dolganiuc
Journal:  Semin Liver Dis       Date:  2007-11       Impact factor: 6.115

7.  A screening method for identifying disruptions in interferon signaling reveals HCV NS3/4a disrupts Stat-1 phosphorylation.

Authors:  Karla J Helbig; Evelyn Yip; Erin M McCartney; Nicholas S Eyre; Michael R Beard
Journal:  Antiviral Res       Date:  2007-12-26       Impact factor: 5.970

8.  Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.

Authors:  M C Villacres; O Literat; M DeGiacomo; W Du; T Frederick; A Kovacs
Journal:  J Viral Hepat       Date:  2008-02       Impact factor: 3.728

9.  Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Authors:  Takayuki Abe; Yuuki Kaname; Itsuki Hamamoto; Yoshimi Tsuda; Xiaoyu Wen; Shuhei Taguwa; Kohji Moriishi; Osamu Takeuchi; Taro Kawai; Tatsuya Kanto; Norio Hayashi; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

10.  Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase.

Authors:  S Ehrt; D Schnappinger; S Bekiranov; J Drenkow; S Shi; T R Gingeras; T Gaasterland; G Schoolnik; C Nathan
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307
View more
  37 in total

Review 1.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

2.  Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.

Authors:  Shubham Shrivastava; Anupam Mukherjee; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

Review 3.  The role of chemokines in acute and chronic hepatitis C infection.

Authors:  Stephen Fahey; Eugene Dempsey; Aideen Long
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

4.  Circulating and Exosome-Packaged Hepatitis C Single-Stranded RNA Induce Monocyte Differentiation via TLR7/8 to Polarized Macrophages and Fibrocytes.

Authors:  Banishree Saha; Karen Kodys; Adeyinka Adejumo; Gyongyi Szabo
Journal:  J Immunol       Date:  2017-01-25       Impact factor: 5.422

Review 5.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

Review 6.  Vaccine therapies for chronic hepatitis B: can we go further?

Authors:  Yumei Wen; Xuanyi Wang; Bin Wang; Zhenhong Yuan
Journal:  Front Med       Date:  2014-01-24       Impact factor: 4.592

7.  Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Authors:  Yu Zhou; Xu Wang; Li Sun; Li Zhou; Tong-Cui Ma; Li Song; Jian-Guo Wu; Jie-Liang Li; Wen-Zhe Ho
Journal:  FASEB J       Date:  2016-09-07       Impact factor: 5.191

8.  Evaluation of Gallium as a Tracer of Exogenous Hemoglobin-Haptoglobin Complexes for Targeted Drug Delivery Applications.

Authors:  Shengsheng Xu; Igor A Kaltashov
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-12       Impact factor: 3.109

9.  Interferon β (IFN-β) Production during the Double-stranded RNA (dsRNA) Response in Hepatocytes Involves Coordinated and Feedforward Signaling through Toll-like Receptor 3 (TLR3), RNA-dependent Protein Kinase (PKR), Inducible Nitric Oxide Synthase (iNOS), and Src Protein.

Authors:  Liyong Zhang; Wenpei Xiang; Guoliang Wang; Zhengzheng Yan; Zhaowei Zhu; Zhong Guo; Rajib Sengupta; Alex F Chen; Patricia A Loughran; Ben Lu; Qingde Wang; Timothy R Billiar
Journal:  J Biol Chem       Date:  2016-05-17       Impact factor: 5.157

10.  High post-treatment absolute monocyte count predicted hepatocellular carcinoma risk in HCV patients who failed peginterferon/ribavirin therapy.

Authors:  Tsung-Ming Chen; Chun-Che Lin; Pi-Teh Huang; Chen-Fan Wen
Journal:  Tumour Biol       Date:  2015-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.